Stay updated with breaking news from Mlas Olsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.
Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europes most valuable company
The Copenhagen Post – your Danish Connection
"If it wasn't for Novo Nordisk there wouldn't have been any growth in the first six months of the year," the chief economist at Danske Bank told AFP.
Pharmaceutical giant Novo Nordisk’s first-mover advantage in weight-loss drugs has singled-handedly saved Denmark from recession. How long will the ride last?